Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

Europe - EPA:UBI - FR0000054470 - Common Stock

8.252 EUR
-0.11 (-1.29%)
Last: 9/17/2025, 3:03:37 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to UBI. UBI was compared to 46 industry peers in the Entertainment industry. The financial health of UBI is average, but there are quite some concerns on its profitability. UBI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year UBI has reported negative net income.
In the past year UBI had a positive cash flow from operations.
In multiple years UBI reported negative net income over the last 5 years.
In the past 5 years UBI always reported a positive cash flow from operatings.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -3.38%, UBI is in line with its industry, outperforming 41.30% of the companies in the same industry.
UBI has a Return On Equity of -8.86%. This is comparable to the rest of the industry: UBI outperforms 47.83% of its industry peers.
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

With an excellent Gross Margin value of 89.33%, UBI belongs to the best of the industry, outperforming 80.43% of the companies in the same industry.
UBI's Gross Margin has been stable in the last couple of years.
UBI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

UBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UBI has more shares outstanding
The number of shares outstanding for UBI has been increased compared to 5 years ago.
The debt/assets ratio for UBI has been reduced compared to a year ago.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that UBI is in the distress zone and has some risk of bankruptcy.
UBI has a Altman-Z score (1.10) which is in line with its industry peers.
The Debt to FCF ratio of UBI is 2.24, which is a good value as it means it would take UBI, 2.24 years of fcf income to pay off all of its debts.
UBI has a Debt to FCF ratio of 2.24. This is in the better half of the industry: UBI outperforms 69.57% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that UBI has dependencies on debt financing.
The Debt to Equity ratio of UBI (1.02) is worse than 60.87% of its industry peers.
Although UBI does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Altman-Z 1.1
ROIC/WACCN/A
WACC5.36%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.68, UBI belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.68, UBI belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for UBI have decreased strongly by -131.28% in the last year.
Looking at the last year, UBI shows a very negative growth in Revenue. The Revenue has decreased by -17.46% in the last year.
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

The Earnings Per Share is expected to grow by 33.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, UBI will show a small growth in Revenue. The Revenue will grow by 5.22% on average per year.
EPS Next Y30.99%
EPS Next 2Y75.56%
EPS Next 3Y64.93%
EPS Next 5Y33.68%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.61%
Revenue Next 5Y5.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UBI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UBI is valued cheaply inside the industry as 84.78% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.13
EV/EBITDA 3.35
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as UBI's earnings are expected to grow with 64.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.56%
EPS Next 3Y64.93%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (9/17/2025, 3:03:37 PM)

8.252

-0.11 (-1.29%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-22 2025-07-22
Earnings (Next)10-28 2025-10-28
Inst Owners36.11%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.09B
Analysts55.24
Price Target11.42 (38.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-144.94%
EPS NY rev (3m)-144.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-13.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF 1.13
P/OCF 1.08
P/B 0.61
P/tB N/A
EV/EBITDA 3.35
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)7.29
FCFY88.37%
OCF(TTM)7.61
OCFY92.2%
SpS14.32
BVpS13.54
TBVpS-3.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.33%
FCFM 50.92%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Debt/EBITDA 2.7
Cap/Depr 5.9%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 148.22%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 1.1
F-Score3
WACC5.36%
ROIC/WACCN/A
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y30.99%
EPS Next 2Y75.56%
EPS Next 3Y64.93%
EPS Next 5Y33.68%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.61%
Revenue Next 5Y5.22%
EBIT growth 1Y-109.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1517.96%
EBIT Next 3Y172.56%
EBIT Next 5Y83.7%
FCF growth 1Y129.47%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y87.67%
OCF growth 3Y12.65%
OCF growth 5Y10.94%